Announcements Trials
Browse Landscape

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

tislelizumab 7Paclitaxel 5Radiotherapy 4Carboplatin 4Oxaliplatin 3Immune Checkpoint Inhibitors 3nedaplatin 2Radiation 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cisplatin 2Albumin-Bound Paclitaxel 2tranilast 1toripalimab 1sintilimab 1irinotecan sucrosofate 1camrelizumab 1apatinib 1anlotinib 1Surgical Procedures, Operative 1Specimen Handling 1Simvastatin 1S 1 (combination) 1Robotic Surgical Procedures 1Radiosurgery 1Pemetrexed 1Patient Reported Outcome Measures 1Observation 1Nutrition Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Esophageal Neoplasms × Breath Tests × Clear all
NCT07260734 2025-12-03

AROMA2

Imperial College London

Not yet recruiting
6,000 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡